+1.800.595.1106 [email protected]

Granix new growth factor now approved for reduction of neutropenia in patients with non-myeloid malignancies…Learn more

Valchlor new topical agent now approved for reduction of stage IA and IB mycosis fungoides…Learn more

Opsumit is a new endothelial receptor antagonist for the treatment of pulmonary arterial hypertension…Learn more